Outcome of carcinoid heart syndrome in patients enrolled in the SwissNet cohort
Abstract Background Carcinoid heart disease is a rare disease which develops in patients with functional neuroendocrine tumors in an advanced tumor state. Patients diagnosed with carcinoid heart disease have a poor longtime prognosis with respect to morbidity and mortality and long-term data on pati...
Main Authors: | Eva Grundmann, Alessandra Curioni-Fontecedro, Emanuel Christ, Alexander R. Siebenhüner |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-10739-z |
Similar Items
-
Additional malignancies in patients with neuroendocrine tumours: analysis of the SwissNET registry
by: Attila Kollár, et al.
Published: (2016-11-01) -
Ablation of typical atrial flutter as therapeutic component in carcinoid heart disease: a case report
by: Susann Groschke, et al.
Published: (2022-02-01) -
Hedinger Syndrome—Lessons Learnt: A Single-Center Experience
by: Mohamed El Gabry, et al.
Published: (2023-10-01) -
Biomarkers in Small Intestine NETs and Carcinoid Heart Disease: A Comprehensive Review
by: Markos Kalligeros, et al.
Published: (2021-09-01) -
Double valve replacement in a case of Hedinger syndrome
by: Presheet Pathare, et al.
Published: (2023-01-01)